MedX Holdings, Inc. (OTC: MEDH) Med X Holdings Q2 2025 Investor Update: Were at an Inflection Point
Austin, Texas, Aug. 19, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MedX…
Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum
Expenses significantly lower with expansion on multiple efforts; Q2 2025 loss from…
IPSEN – Buy-back programme – Art 5 of MAR – Week 33 – 2025
Aggregated presentation by day and by marketStatement of transactions in own shares…
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2025 16:35 ET | Source: Vor Biopharma CAMBRIDGE, Mass., Aug.…
Invivyd Announces Continued Neutralizing Activity of PEMGARDA (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (Stratus)
August 18, 2025 16:32 ET | Source: Invivyd New in vitro neutralization…
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
WOODCLIFF LAKE, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc.…
SOVRA Sharpens Focus on GovTech Sector with Series of Strategic Updates
MONTREAL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- SOVRA (formerly mdf commerce) ("SOVRA"…
Key Labs accelerates crypto token growth with advanced market making, algorithmic trading strategies & liquidity solutions
LONDON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Key Labs, a boutique provider…
Elyor Platform: Market Experts & Traders Discuss Elyor Platform For Its Cutting-Edge AI, Security, and Performance Metrics – Read Australia Trading Report!
New York City, NY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Introduction: Elyor…
Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage…
